HCM
BEAT

Highbridge Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Highbridge Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,200
Closed -$246K – 1992
2017
Q4 		$246K Buy
+8,200
New +$237K ﹤0.01% 1370

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's BEAT Position: Q3 2016 in Review

Highbridge Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2016, closing a stake of 25,289 shares — an estimated $413K sold.

Highbridge Capital Management first reported a position in BEAT in Q4 2013 and held it in 10 quarters. The position peaked at $994K in Q4 2013. 167 funds tracked by Wall St. Rank hold BEAT as of Q3 2016.

  • Highbridge Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 25,289 BioTelemetry, Inc. shares in Q3 2016, an estimated $413K.
  • Highbridge Capital Management first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 10 quarters.
  • Highbridge Capital Management's BioTelemetry, Inc. position peaked at $994K in Q4 2013.
  • 167 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.